RxDoctor Payments Data

Carol Miyake

Endocrinology, Diabetes & Metabolism · Poughkeepsie, NYNPI 1760408330

Payments from drug & device makers

$3,470in general payments, 2019–2025

Across 205 payments — averaging $16.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$392
  • GSK$364
  • AbbVie$358
  • AstraZeneca$338
  • Lilly USA, LLC$234
  • Johnson & Johnson$231
  • plus $2K from 25 others

What the payments were for

  • Food & beverage$3,37497%
  • Education$361%
  • Gifts$592%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,470 in reported general payments places this provider in the 65th percentile of 804 endocrinology, diabetes & metabolism providers in New York.

See all endocrinology, diabetes & metabolism providers in New York

Other endocrinology, diabetes & metabolism in Poughkeepsie

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →